This Article Full Text Full Text (PDF) Supplementary Data All Versions of this Article: 0008-5472.CAN-09-1299v1 69/18/7224    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Bhatia, B. Articles by Kenney, A. M. PubMed PubMed Citation Articles by Bhatia, B. Articles by Kenney, A. M.

Tuberous Sclerosis Complex Suppression in Cerebellar Development and Medulloblastoma: Separate Regulation of Mammalian Target of Rapamycin Activity and p27^Kip1 Localization

¹ Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, New York; ² Division of Neurosurgery, The Hospital for Sick Children, The University of Toronto, Toronto, Ontario, Canada; and ³ Department of Dermatology, Emory School of Medicine, Atlanta, Georgia

Requests for reprints: Anna Marie Kenney, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10021. Phone: 646-888-2051; Fax: 646-422-0231; E-mail: kenneya{at}mskcc.org.

Key Words: TSC • Sonic hedgehog • cerebellum • medulloblastoma • p27^Kip1 • mTOR

During development, proliferation of cerebellar granule neuron precursors (CGNP), candidate cells-of-origin for the pediatric brain tumor medulloblastoma, requires signaling by Sonic hedgehog (Shh) and insulin-like growth factor (IGF), the pathways of which are also implicated in medulloblastoma. One of the consequences of IGF signaling is inactivation of the mammalian target of rapamycin (mTOR)–suppressing tuberous sclerosis complex (TSC), comprised of TSC1 and TSC2, leading to increased mRNA translation. We show that mice, in which TSC function is impaired, display increased mTOR pathway activation, enhanced CGNP proliferation, glycogen synthase kinase-3/β (GSK-3/β) inactivation, and cytoplasmic localization of the cyclin-dependent kinase inhibitor p27^Kip1, which has been proposed to cause its inactivation or gain of oncogenic functions. We observed the same characteristics in wild-type primary cultures of CGNPs in which TSC1 and/or TSC2 were knocked down, and in mouse medulloblastomas induced by ectopic Shh pathway activation. Moreover, Shh-induced mouse medulloblastomas manifested Akt-mediated TSC2 inactivation, and the mutant TSC2 allele synergized with aberrant Shh signaling to increase medulloblastoma incidence in mice. Driving exogenous TSC2 expression in Shh-induced medulloblastoma cells corrected p27^Kip1 localization and reduced proliferation. GSK-3/β inactivation in the tumors in vivo and in primary CGNP cultures was mTOR-dependent, whereas p27^Kip1 cytoplasmic localization was regulated upstream of mTOR by TSC2. These results indicate that a balance between Shh mitogenic signaling and TSC function regulating new protein synthesis and cyclin-dependent kinase inhibition is essential for the normal development and prevention of tumor formation or expansion. [Cancer Res 2009;69(18):7224–34]